Free Trial

Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase

Tectonic Therapeutic logo with Medical background

Tectonic Therapeutic (NASDAQ:TECX - Get Free Report) saw an uptick in trading volume on Tuesday . 35,556 shares were traded during mid-day trading, an increase of 52% from the previous session's volume of 23,456 shares.The stock last traded at $15.90 and had previously closed at $15.90.

Wall Street Analysts Forecast Growth

Several brokerages have commented on TECX. Piper Sandler began coverage on shares of Tectonic Therapeutic in a report on Wednesday, June 26th. They issued an "overweight" rating and a $76.00 price objective for the company. TD Cowen assumed coverage on shares of Tectonic Therapeutic in a report on Monday, June 24th. They set a "buy" rating for the company.

Check Out Our Latest Analysis on TECX

Tectonic Therapeutic Stock Performance

The firm has a market cap of $704.10 million, a PE ratio of 22.74 and a beta of 2.55.

Tectonic Therapeutic (NASDAQ:TECX - Get Free Report) last released its earnings results on Thursday, May 9th. The company reported ($0.15) earnings per share (EPS) for the quarter. As a group, analysts expect that Tectonic Therapeutic will post -5 EPS for the current fiscal year.

About Tectonic Therapeutic

(Get Free Report)

Avrobio, Inc is a bio-technology company. It develops step-change cell and gene therapies for the treatment of cancer and rare disease. The company operates primarily in the United States and Canada. Avrobio, Inc is based in MA, United States.

Recommended Stories

→ Obama’s DNC coup (From Stansberry Research) (Ad)

Should you invest $1,000 in Tectonic Therapeutic right now?

Before you consider Tectonic Therapeutic, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tectonic Therapeutic wasn't on the list.

While Tectonic Therapeutic currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Reverse Stock Splits: What Investors Need to Know
Trump Media Stock Surges on Debate & Legal Drama
Dividend Traps: How to Identify and Avoid Them

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines